The FDA’s new plan to limit access to Covid-19 boosters to older adults and those at high risk isn’t just a policy update — it’s a long-overdue course correction.
Substack is the home for great culture
The FDA’s new plan to limit access to Covid-19 boosters to older adults and those at high risk isn’t just a policy update — it’s a long-overdue course correction.